Sarepta Therapeutics, Inc. (0L35.L) LSE

22.30

+0.9313(+4.36%)

Updated at December 24 05:59PM

Currency In USD

Valuation

Market Cap11.56B
Enterprise Value11.8B
P/E Ratio-8.1
PEG Ratio0.02
Price/Sales Ratio0.91
Price/Book Ratio1.67
Enterprise/Revenue1.17
Enterprise/EBITDA-15.14

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin-0.11
Operating Margin-0.05

Management Effectiveness

Return On Assets-0.08
Return On Equity-0.2

Income Statement

Revenue1.9B
Revenue/Share24.49
Gross Profit1.58B
EBITDA316.89M
Net Income235.24M
Diluted EPS2.34

Balance Sheet

Total Cash850.99M
Total Cash/Share8.64
Total Debt1.25B
Total Debt/Equity0.95
Current Ratio2.95
Book Value Per Share13.4

Price History

52-Week Change-81.67
52-Week High155.48
52-Week Low21.9
Moving Average 50 Days121.03
Moving Average 200 Days112.45

Statistics

Average Volume424
Shares Outstanding97.98M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A